Health Canada drug identification number

DIN 02083523 — BEZALIP SR 400 MG

BEZALIP SR is a tablet (extended-release) of Bezafibrate marketed by ALLERGAN INC. The full Bezafibrate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02083523
Brand name
BEZALIP SR
Active ingredient
Bezafibrate
Strength
400 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
ALLERGAN INC
Health Canada status
MARKETED
Drug class
Fibric acid derivative (fibrate) lipid metabolism regulator

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Bezafibrate products

DINBrandStrengthFormManufacturerStatus
02453312 JAMP-BEZAFIBRATE SR 400 MG TABLET (EXTENDED-RELEASE) JAMP PHARMA CORPORATION MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.